Dean J. Mitchell

President, Bristol-Myers Squibb.

Companies

Praxis Precision Medicines, Inc.Board member Oct 15, 2020 to now¹
Theravance Biopharma, Inc.Board member Jun 5, 2014 to now²
Kinnate Biopharma Inc.Board member Dec 2, 2020 to Apr 5, 2024³
Precigen, IncBoard member Aug 7, 2013 to Mar 18, 2024⁴
ImmunoGen Inc.Board member Feb 1, 2012 to Feb 12, 2024⁵
Bristol-Myers SquibbPresident Sep 12, 2003 to Sep 12, 2003⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Bristol-Myers Squibb BMY60,568 shares⁷$3.6M at $59.67Sep 12, 2003

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 10, 2003Granted 10,000 shares of Bristol-Myers Squibb⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPraxis Precision Medicines, Inc., Board member
2
SEC EDGARTheravance Biopharma, Inc., Board member
3
SEC EDGARKinnate Biopharma Inc., Board member
4
SEC EDGARPrecigen, Inc, Board member
5
SEC EDGARImmunoGen Inc., Board member
6
SEC EDGARBristol-Myers Squibb, President
7
SEC EDGARBristol-Myers Squibb shares after the filing of Sep 12, 2003